Margje (Marthe) Haverkamp

Margje (Marthe) Haverkamp (HF 2015-16) was a 2015 Dutch Harkness Fellow at the Harvard T.H. Chan School of Public Health, where she worked on value-based care and cost-reduction strategies. Following her fellowship, Marthe helped pharma start-up companies develop their novel therapeutic products. Since 2019, Marthe has been a Senior Director with Alvarez & Marsal’s Healthcare Industry Group (HIG) in New York, where she works with academic medical centers, physician practices and community-based organizations on strategy, physician governance, and operational efficiencies. She draws from more than 20 years of experience throughout the healthcare sector in the U.S. and internationally. Marthe started her career as an Infectious Disease specialist in the Leiden University Medical Center in the Netherlands with a scholarship of the European Society of Immunodeficiencies (ESID). Along with her clinical work, she served as a supporting member of the Council for Public Health and Healthcare (RVZ). Marthe earned a M.D. from the University of Utrecht and a Ph.D. in immunogenetics from the University of Leiden with a clinical research grant of the Dutch Research Council (NWO). She performed part of her Ph.D. at the National Institutes of Health (NIH) on a Fulbright Fellowship and has participated in executive leadership courses at HBS and INSEAD as a Leadership Foundation Fellow of the International Women’s Forum (IWF). She has published close to 40 articles, mostly peer reviewed. Dr. Haverkamp is a Fellow of the American College of Healthcare Executives (FACHE), and an Associate Faculty Member of the Ariadne Labs